ERIS Lifesciences Ltd Annually Results

Gross Sales

2,879.26

1,991.3

1,661.82

1,326.17

1,192.64

Excise Duty

0

0

0

0

0

Net Sales

2,879.26

1,991.3

1,661.82

1,326.17

1,192.64

Other Operating Income

14.38

17.85

23.33

20.88

19.22

Other Income

18.42

23.82

11.15

26.09

8.71

Total Income

2,912.06

2,032.97

1,696.3

1,373.14

1,220.57

Total Expenditure

1,876.44

1,334.32

1,148.4

862.09

781.29

PBIDT

1,035.62

698.65

547.9

511.05

439.28

Interest

231.29

84.8

26.17

4.15

1.8

PBDT

804.33

613.85

521.73

506.9

437.48

Depreciation

315.46

182.51

117.09

64.71

42.99

Minority Interest Before NP

0

0

0

0

0

Tax

111.84

82.22

74.66

81.82

69.4

Deferred Tax

2.36

-48

-44.18

-45.42

-30.04

Reported Profit After Tax

374.67

397.12

374.16

405.79

355.14

Minority Interest After NP

22.83

5.07

-8

-0.32

0

Net Profit after Minority Interest

351.84

392.05

382.16

406.11

355.14

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

351.84

392.05

382.16

406.11

355.14

EPS (Unit Curr.)

25.85

28.82

28.1

29.89

26.16

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

735

0

735

601

550

Equity

13.62

13.6

13.6

13.59

13.58

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.96

35.08

32.96

38.53

36.83

PBDTM(%)

27.93

30.82

31.39

38.22

36.68

PATM(%)

13.01

19.94

22.51

30.59

29.77